Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX Treatment in Adult Patients with Post-Stroke Lower Limb Spasticity
2011-004980-63Phase 3Completed
- Sponsor
- Allergan
- Start
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of botulinum toxin type A in lower extremity spasticity, sponsored by Allergan. Primary endpoints: MAS-B score for ankle plantar flexors and CGI by Physician. Started Dec 2011; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
lower extremity spasticity
Beyond the preview
Go deeper on 2011-004980-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004980-63.